Altimmune ALT
NASDAQ ALT
$3.39 +0.16 (+4.95%)
As of: Sep 4, 2026 · 3:16 PM EDT

Altimmune (ALT) Debt Ratio (2012 - 2026)

Altimmune (ALT) posted quarterly Debt Ratio of 0.1 for Q1 2026, down 16.07% quarter-over-quarter from 0.12 in Q4 2025.

Analysis

Altimmune (ALT) Debt Ratio (2012 - 2026) Analysis & Trends

Altimmune (ALT) has reported Debt Ratio for 14 consecutive years, with 0.1 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Debt Ratio changed N/A year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (changed N/A YoY), while the FY2025 annual figure was 0.12, changed N/A from the prior year.
  • Debt Ratio fell to 0.1 in Q1 2026 per ALT's latest filing, from 0.12 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.12 in Q4 2025 and bottomed at 0.01 in Q2 2022.
  • Historically, Debt Ratio has averaged 0.05 across 4 years, with a median of 0.03 in 2023.
  • On a YoY basis, Debt Ratio climbed as much as 346.72% in 2022 and fell as far as 35.77% in 2022.
  • Altimmune's Debt Ratio stood at 0.02 in 2022, then advanced by 16.74% to 0.03 in 2023, then soared by 373.93% to 0.12 in 2025, then dropped by 16.07% to 0.1 in 2026.
  • Business Quant data shows ALT's Debt Ratio at 0.1 in Q1 2026, 0.12 in Q4 2025, and 0.07 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn 0.05
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn -
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn 0.05
5 Revolution Medicines 44.02 Bn 44.02 Bn - -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn 0.12
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn -
8 Royalty Pharma 28.43 Bn 27.59 Bn - 0.47
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 0.26
10 Altimmune 628.10 Mn 628.10 Mn - 0.07
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.07
Mar 31, 2026 0.10
Dec 31, 2025 0.12
Sep 30, 2025 0.07
Jun 30, 2025 0.08
Sep 30, 2023 0.03
Jun 30, 2023 0.02
Mar 31, 2023 0.02
Dec 31, 2022 0.02
Sep 30, 2022 0.02
Jun 30, 2022 0.01
Mar 31, 2022 0.03
Dec 31, 2021 0.03
Sep 30, 2021 0.01
Jun 30, 2021 0.01
Mar 31, 2021 0.01
Dec 31, 2020 0.01
Sep 30, 2020 0.01
Jun 30, 2020 0.02
Mar 31, 2020 0.03